Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relugolix vs Leuprorelin in Prostate Cancer
NCT02083185Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Mar 2014
- Primary completion
- Jan 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 2
01
Overview
A Phase 2 trial of tissue-plasminogen activator in prostate cancer (PCa), sponsored by Millennium Pharmaceuticals. Started Mar 2014; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02083185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02083185.